The co-delivery of survivin siRNA and paclitaxel using this nanocarrier was minimally toxic to brain capillary endothelial cells but selectively caused apoptosis of CD133+ glioma stem cells and improved the differentiation of CD133+ glioma stem cells’ into non-stem-cell lineages. The gene discussed is PROM1; the disease is central nervous system cancer.